1 |
Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 2011;35:190-201.
DOI
|
2 |
Al-Qaderi A, Mansour AT. Pseudomyogenic hemangioendothelioma. Arch Pathol Lab Med 2019;143:763-7.
DOI
|
3 |
Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 2003;27:48-57.
DOI
|
4 |
Pranteda G, Magri F, Muscianese M, et al. The management of pseudomyogenic hemangioendothelioma of the foot: a case report and review of the literature. Dermatol Ther 2018;31:e12725.
DOI
|
5 |
Horan NA, DiMaio DJ. Pseudomyogenic hemangioendothelioma. Cutis 2017;100:E13-6.
|
6 |
Inyang A, Mertens F, Puls F, et al. Primary pseudomyogenic hemangioendothelioma of bone. Am J Surg Pathol 2016;40:587-98.
DOI
|
7 |
Fan C, Yang L, Lin X, Wang E. Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case. Diagn Pathol 2015;10:150.
DOI
|
8 |
Sun Y, Zhao M, Lao IW, Yu L, Wang J. The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature. Virchows Arch 2020;477:231-40.
DOI
|
9 |
Agaram NP, Zhang L, Cotzia P, Antonescu CR. Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions. Am J Surg Pathol 2018;42:1653-61.
DOI
|